M. Jules Mattes

3.8k total citations
94 papers, 3.2k citations indexed

About

M. Jules Mattes is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, M. Jules Mattes has authored 94 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Radiology, Nuclear Medicine and Imaging, 39 papers in Molecular Biology and 28 papers in Immunology. Recurrent topics in M. Jules Mattes's work include Monoclonal and Polyclonal Antibodies Research (66 papers), Radiopharmaceutical Chemistry and Applications (42 papers) and Glycosylation and Glycoproteins Research (26 papers). M. Jules Mattes is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (66 papers), Radiopharmaceutical Chemistry and Applications (42 papers) and Glycosylation and Glycoproteins Research (26 papers). M. Jules Mattes collaborates with scholars based in United States, Poland and Italy. M. Jules Mattes's co-authors include Gaik Lin Ong, David M. Goldenberg, Kenneth O. Lloyd, Lloyd J. Old, Rhona Stein, Gary L. Griffiths, Rosana Michel, Serengulam V. Govindan, Lisa B. Shih and Hans J. Hansen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

M. Jules Mattes

94 papers receiving 3.0k citations

Peers

Countries citing papers authored by M. Jules Mattes

Since Specialization

Citations

This map shows the geographic impact of M. Jules Mattes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Jules Mattes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Jules Mattes more than expected).

Fields of papers citing papers by M. Jules Mattes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Jules Mattes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Jules Mattes. The network helps show where M. Jules Mattes may publish in the future.

Co-authorship network of co-authors of M. Jules Mattes

This figure shows the co-authorship network connecting the top 25 collaborators of M. Jules Mattes. A scholar is included among the top collaborators of M. Jules Mattes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Jules Mattes. M. Jules Mattes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Induction of Apoptosis by Cross-Linking Antibodies Bound to Human B-Lymphoma Cells: Expression of Annexin V Binding Sites on the Antibody Cap 2009 ·Cancer Biotherapy and Radiopharmaceuticals ·M. Jules Mattes, Rosana Michel, David M. Goldenberg, Robert M. Sharkey	8
2	Apoptosis assays with lymphoma cell lines: problems and pitfalls 2007 ·British Journal of Cancer ·M. Jules Mattes	17
3	177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo 2005 ·Nuclear Medicine and Biology ·Rosana Michel, (unknown), (unknown), David M. Goldenberg, M. Jules Mattes	32
4	Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments 2004 ·British Journal of Cancer ·Rosana Michel, M. Jules Mattes	4
5	Binding parameters of antibodies: pseudo-affinity and other misconceptions 2004 ·Cancer Immunology Immunotherapy ·M. Jules Mattes	10
6	Use of Galactosylated-Streptavidin as a Clearing Agent with ¹¹¹ In-Labeled, Biotinylated Antibodies to Enhance Tumor/Non-Tumor Localization Ratios 2002 ·Cancer Biotherapy and Radiopharmaceuticals ·Serengulam V. Govindan, Gary L. Griffiths, Rosana Michel, (unknown), David M. Goldenberg, M. Jules Mattes	5
7	Localization of an antibody to CD74 (MHC class II invariant chain) to human B cell lymphoma xenografts in nude mice 2000 ·Cancer Immunology Immunotherapy ·Lisa B. Shih, Gaik Lin Ong, J. D. Burton, (unknown), David M. Goldenberg, M. Jules Mattes	6
8	Processing of antibodies to the MHC class II antigen by B-cell lymphomas: release of Fab-like fragments into the medium 1999 ·Molecular Immunology ·Gaik Lin Ong, M. Jules Mattes	10
9	Intracellular processing of 99Tcm-antibody conjugates 1998 ·Nuclear Medicine Communications ·Habibe Karacay, Gaik Lin Ong, H. J. Hansen, Gary L. Griffiths, David M. Goldenberg, M. Jules Mattes	12
10	Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22 1997 ·Cancer Immunology Immunotherapy ·Robert M. Sharkey, Thomas M. Behr, M. Jules Mattes, Rhona Stein, Gary L. Griffiths, Lisa B. Shih, Hans J. Hansen, Rosalyn D. Blumenthal, Robert M. Dunn, Malik E. Juweid, David M. Goldenberg	70
11	The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody 1997 ·International Journal of Cancer ·M. Jules Mattes, Lisa B. Shih, Serengulam V. Govindan, Robert M. Sharkey, Gaik Lin Ong, Xuan Hong, David M. Goldenberg	24
12	Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells 1994 ·Cancer ·M. Jules Mattes, Gary L. Griffiths, (unknown), David M. Goldenberg, Gaik Lin Ong, Lisa B. Shih	81
13	The fate of antibodies and their radiolabels bound to tumor cells in vitro: The effect of cross-linking at the cell surface and of anti-idiotype antibodies 1994 ·Cancer Immunology Immunotherapy ·Gaik Lin Ong, (unknown), M. Jules Mattes	3
14	Characterization of cluster 13: The epithelial/carcinoma antigen recognized by MAb RS7 1994 ·International Journal of Cancer ·Rhona Stein, Amartya Basu, David M. Goldenberg, Kenneth O. Lloyd, M. Jules Mattes	30
15	Biochemical and immunological characterization of the human carcinoma‐associated antigen MH 99/KS 1/4 1993 ·International Journal of Cancer ·Michael P. Schön, Margarete Schön, (unknown), (unknown), M. Jules Mattes, Rhona Stein, Lutz Weber, Saverio Alberti, Christophe Klein	41
16	Re-evaluation of the concept of functional affinity as applied to bivalent antibody binding to cell surface antigens 1993 ·Molecular Immunology ·Gaik Lin Ong, M. Jules Mattes	36
17	The Specificity of Alternative Complement Pathway‐Mediated Lysis of Erythrocytes: A Survey of Complement and Target Cells from 25 Species 1993 ·Scandinavian Journal of Immunology ·(unknown), Gaik Lin Ong, Naishadh Desai, M. Jules Mattes	37
18	Mouse strains with typical mammalian levels of complement activity 1989 ·Journal of Immunological Methods ·Gaik Lin Ong, M. Jules Mattes	120
19	Pigmentation-Associated Glycoprotein of Human Melanomas and Melanocytes: Definition with a Mouse Monoclonal Antibody 1985 ·Journal of Investigative Dermatology ·Timothy M. Thomson, M. Jules Mattes, Linda Le Roux, Lloyd J. Old, Kenneth O. Lloyd	107
20	Monoclonal Antibodies to Three Widely Distributed Human Cell Surface Antigens 1983 ·Hybridoma ·M. Jules Mattes, J. Gregory Cairncross, Lloyd J. Old, Kenneth O. Lloyd	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact